Urgent action for e-cigarette epidemic

2Firsts Events
Jul.06.2022
A number of Victorian health organisations are calling for urgent action to protect current and future generations from becoming dependent on harmful e-cigarettes and start smoking.

Quit Victoria, VicHealth and Cancer Council Victoria are calling for urgent action to protect current and future generations from becoming dependent on harmful e-cigarettes and start smoking.

 

The Four Corners program on ABC recently showed the extent to which importers and retailers in a multi-billion-dollar industry are breaking the law, by selling e-cigarettes to children.

Urgent action for e-cigarette epidemic

Recently the National Health and Medical Research Council (NHMRC) released a comprehensive evidence review, which concluded that e-cigarette aerosol is harmful to health and that people who use e-cigarettes are highly likely to go on to smoke.

 

“The NHMRC review found that e-cigarettes present very real dangers to children and youth,” said VicHealth Chief Executive Officer Dr Sandro Demaio.

 

“We’re hearing from parents and community leaders, and teens themselves, that vaping is a huge issue for communities around Victoria.

 

“The liquid in e-cigarettes contains dozens of toxic chemicals including formaldehyde, nicotine and heavy metals. These are chemicals that are known to cause cancer and damage the brain and do not belong in our lungs.”

 

Cancer Council Victoria Chief Executive Officer Todd Harper said that surveys conducted by the Cancer Council had shown high levels of community support for measures that protect children from vaping and smoking.

 

“There are serious community concerns right now and strong support for action,” Mr Harper said.

 

“The need for a licensing scheme for cigarette and e-cigarette retailers in Victoria, to simplify and strengthen enforcement of laws, is now critical.

 

“We need the federal government to do more to stop unlawful e-cigarette imports, sure, but we also need to ensure there are consequences for retailers in Victoria who are knowingly doing the wrong thing and illegally selling harmful e-cigarettes to children.

 

“The Victorian Government has the opportunity to introduce a gold-standard licensing scheme and really show the way in Australia.”

 

The content excerpted or reproduced in this article comes from a third-party, and the copyright belongs to the original media and author. If any infringement is found, please contact us to delete it. Any entity or individual wishing to forward the information, please contact the author and refrain from forwarding directly from here.

NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
Why AIRSCREAM Built its European Production Hub for Regulated Market Growth
AIRSCREAM’s production hub in the Czech Republic brings nicotine pouch manufacturing, e-liquid bottling, product documentation, warehousing and international logistics into one operation, giving brands and commercial partners a practical platform from which to launch, expand and enter new markets.
Market
Sep.16 by 2Firsts Perspectives
How Many Nicotine Pouch Factories Does Europe Need? 2Firsts Interviews AIRSCREAM on the OEM Market
How Many Nicotine Pouch Factories Does Europe Need? 2Firsts Interviews AIRSCREAM on the OEM Market
At InterTabac 2026, nicotine pouch growth was visible not only in brands but across equipment, raw materials and OEM manufacturing. 2Firsts interviewed AIRSCREAM commercial head Steve Moore on how many pouch factories Europe may ultimately need and where manufacturers can differentiate, from formulation and flavour to pouch materials, production consistency and customer service. The category continues to expand, but questions remain over future capacity, consolidation and the long-term structure of the supply chain.
Sep.18
IQOS Enters Kantar BrandZ Global Top 100 for First Time, Valued at $36.6 Billion and Ranked No. 74
IQOS Enters Kantar BrandZ Global Top 100 for First Time, Valued at $36.6 Billion and Ranked No. 74
Philip Morris International’s IQOS has entered the Kantar BrandZ Top 100 Most Valuable Global Brands for the first time, ranking No. 74 with a brand value of $36.634 billion and becoming one of only three newcomers to the 2026 ranking. Kantar said the combined value of the Global Top 100 reached $13.1 trillion, up 22% year on year, while the threshold for entry rose to a record high. PMI says IQOS has more than 35 million users worldwide and surpassed $10 billion in annual net revenues within a decade of launch.
Sep.03
Switzerland Tightens Vape Checks as Only 3 of 32 Tested Products Meet New Tobacco Rules
Switzerland Tightens Vape Checks as Only 3 of 32 Tested Products Meet New Tobacco Rules
According to Swiss media outlet Blick, local authorities are strengthening compliance checks on vape products, nicotine pouches and other tobacco-related products following the implementation of Switzerland’s revised Tobacco Products Act. A Basel laboratory tested 32 disposable vapes and e-liquids, with only three meeting regulatory requirements and 21 products banned from sale. Swiss authorities are also expanding retail inspections, laboratory testing and youth purchase checks to enforce the new tobacco and nicotine product rules.
Aug.12
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane 2026 Update Adds Nine Trials, Keeps High-Certainty Finding That Nicotine E-Cigarettes Improve Quit Rates Over NRT
Cochrane’s 2026 update of its living review on electronic cigarettes for smoking cessation included 80 randomized controlled trials involving 29,861 adult smokers, with nine trials added in this update. The review retained its high-certainty conclusion that nicotine e-cigarettes increase smoking cessation rates compared with nicotine replacement therapy. In absolute terms, about 10 in 100 people using nicotine e-cigarettes may quit smoking for at least six months, compared with about 6 in 100 using NRT. The review found no clear difference in serious adverse event rates between the two groups, while longer-term safety and the relative effectiveness of newer device types remain less certain.
Sep.07